Sasha Joseph

Dr. Sasha Joseph is a Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine, practicing at Fred Hutchinson Cancer Center's UW Medical Center – Northwest facility. His clinical expertise spans solid and hematologic malignancies, benign hematology, and general medical oncology within community-based cancer care settings.

His educational background includes:

• Undergraduate Degree: University of California, San Diego
• Medical Degree: Temple University School of Medicine
• Residency in Internal Medicine: Temple University Hospital
• Fellowship in Hematology/Oncology: New York University

Board certified in Internal Medicine (2009, 2024) and Medical Oncology (2014) by the American Board of Internal Medicine, Dr. Joseph focuses on translational oncology research with emphasis on lung cancer biomarkers, targeted therapies for solid tumors, and hemophilia gene therapy applications. His work bridges molecular diagnostics with clinical implementation in community oncology settings.

Publication analysis reveals concentrated research activity in 2012 addressing biomarker validation for lung cancer screening and comprehensive reviews of targeted solid tumor therapies, demonstrating consistent focus on improving diagnostic precision and treatment personalization in oncology. The 2004 gene therapy study indicates earlier contributions to hemophilia treatment research.

No scientific awards are documented in the provided materials.

Dr. Joseph operates within Fred Hutch's multidisciplinary care framework, collaborating with patient care coordinators, nurses, and advanced practice providers. His clinical trial involvement suggests active research participation though specific grant details remain unspecified. Community oncology initiatives form a core component of his practice model.

Integrated into Fred Hutch's comprehensive support ecosystem, his clinical team includes specialized resources in nutritional support, psychosocial care, complementary therapies, and psychiatric services tailored for cancer and blood disorder patients at the Northwest campus.